Sustained response after rilzabrutinib discontinuation in multirefractory immune thrombocytopenia. - González-López TJ; Orza F; Cuesta-García A; Pérez-Gómez N; Fedele JL; Provan D; Kuter DJ (Blood vessels, thrombosis & hemostasis, 2026)